Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2026 Earnings Call Transcript May 7, 2026
Cytek Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.08.
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Cytek Biosciences First Quarter 2026 Earnings Conference Call. [Operator Instructions] I will now turn the conference over to Paul Goodson, Head of Investor Relations. You may begin.
Paul...
